Company: VSA
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001213900-25-109735
Chunk: 30

Company: VisionSys AI Inc
Filing Date: 2025-11-13
Form: 424B5
Chunk 30
---
 Our BCI Business

Regulatory policies in the medical and technology sectors may change in the jurisdictions where we operate.

The development and use of our core algorithms
and related software-hardware systems for brain-computer interfaces may be subject to evolving regulatory requirements, particularly in
the medical and technology sectors. Regulatory policies in the jurisdictions where we currently operate—primarily in Asia—as
well as in potential future markets, may change or become more stringent. Such changes could lead to increased compliance costs, delays
in product development or deployment, or limitations on our ability to commercialize BCI technologies across different regions.

The actual commercialization progress may fall short of expectations, and the market acceptance of our services or products may be limited.

The development and commercialization of our core
algorithms and related software-hardware systems for brain-computer interface (BCI) technologies are subject to significant uncertainty.
Despite ongoing R&D efforts, the actual progress may fall short of expectations due to technical challenges, regulatory hurdles, or
resource constraints. In addition, the market acceptance of BCI-based products and services remains nascent and unproven at scale. If
users, developers, or commercial partners do not adopt our solutions as anticipated, our business prospects, financial performance, and
competitive position could be adversely affected.

Implementation challenges may arise due to the need to integrate complex software and hardware systems, along with user testing, potentially leading to a prolonged development cycle and deviations from forecast assumptions.

Implementation challenges may arise from the need
to integrate complex software and hardware components within our brain-computer interface systems. This process often involves extensive
user testing, iteration, and system optimization, which can lead to a prolonged development cycle. As a result, there may be delays or
deviations from our projected timelines, cost estimates, or performance assumptions, potentially impacting our ability to achieve commercialization
milestones.

The brain-computer interface industry is competitive, and we may be unable to compete with companies with greater financial or technical resources than us, which could negatively affect our operations.

The sector of brain-computer interfaces is characterized
by rapid technological advancements and fierce competition. Our potential success is contingent upon several factors, including access
to patents and other technology protections, the ability to effectively commercialize technological innovations, the availability of capital,
access to market channels, and obtaining necessary approvals for testing, manufacturing, and commercialization.

We will encounter competition from major global
technology firms, some of which may be integrating state-of-the-art biotechnology, signal analysis, sensor development,